Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative

BACKGROUND: Drug-drug interaction (DDI) is one of the main contributors to adverse drug reactions and therefore, it is important to study its frequency in the population. We aimed to investigate frequency and concordance on CYP2D6, CYP2C19, and CYP2C9 (CYP2D6/2C19/2C9)-mediated potential DDIs at the...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Front Pharmacol
Main Authors: Bahar, Muh. Akbar, Bos, Jens H. J., Borgsteede, Sander D., Dotinga, Aafje, Alingh, Rolinde A., Wilffert, Bob, Hak, Eelko
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2020
נושאים:
Pharmacology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225338/
https://ncbi.nlm.nih.gov/pubmed/32457621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00624
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים